HighTower Advisors »

Larimar Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $173k 39k 4.50

More positions owned by HighTower Advisors

Apple (AAPL)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for HighTower Advisors

Top funds holding Larimar Therapeutics

Deerfield Management Company
Blue Owl Capital Holdings
BlackRock
Millennium Management
Rtw Investments
Vanguard Group
AIGH Capital Management
Vanguard Capital Management
DAFNA Capital Management
Goldman Sachs Group
Deep Track Capital
Woodline Partners
Geode Capital Management
Soleus Capital Management
Point72 Asset Management

View all funds holding Larimar Therapeutics